Is severe COVID-19 a cytokine storm syndrome: a hyperinflammatory debate
P Mehta, DC Fajgenbaum - Current opinion in Rheumatology, 2021 - journals.lww.com
Hyperinflammation is a key component of severe COVID-19, residing underneath the
cytokine storm umbrella term, associated with poor outcomes. Better understanding of the …
cytokine storm umbrella term, associated with poor outcomes. Better understanding of the …
Acute and postacute COVID-19 outcomes for patients with rheumatoid arthritis: lessons learned and emerging directions 3 years into the pandemic
A Zaccardelli, ZS Wallace… - Current opinion in …, 2023 - journals.lww.com
Although COVID-19 outcomes have improved over the pandemic for patients with RA, some
experience poor acute and postacute outcomes after COVID-19. Clinicians and patients …
experience poor acute and postacute outcomes after COVID-19. Clinicians and patients …
Clinical characteristics and outcomes of COVID-19 breakthrough infections among vaccinated patients with systemic autoimmune rheumatic diseases
SARS-CoV-2 vaccines reduce the risk of COVID-19. 1–3 However, some disease-modifying
anti-rheumatic drugs (DMARDs), particularly glucocorticoids, methotrexate, mycophenolate …
anti-rheumatic drugs (DMARDs), particularly glucocorticoids, methotrexate, mycophenolate …
Outcomes with and without outpatient SARS-CoV-2 treatment for patients with COVID-19 and systemic autoimmune rheumatic diseases: a retrospective cohort study
Background Some patients with systemic autoimmune rheumatic disease and
immunosuppression might still be at risk of severe COVID-19. The effect of outpatient SARS …
immunosuppression might still be at risk of severe COVID-19. The effect of outpatient SARS …
[HTML][HTML] Коронавирусная болезнь 2019 (COVID-19) и иммуновоспалительные ревматические заболевания. Рекомендации Общероссийской общественной …
ЕЛ Насонов, АМ Лила, ВИ Мазуров… - Научно …, 2021 - cyberleninka.ru
В середине 2021 года инфекция SARS-CoV-2 (Severe Acute Respiratory coronavirus 2),
вызвавшая пандемию коронавирусной болезни 2019 (coronavirus disease, COVID-19) …
вызвавшая пандемию коронавирусной болезни 2019 (coronavirus disease, COVID-19) …
DMARD disruption, rheumatic disease flare, and prolonged COVID-19 symptom duration after acute COVID-19 among patients with rheumatic disease: a prospective …
Objective To describe disease-modifying antirheumatic drug (DMARD) disruption, rheumatic
disease flare/activity, and prolonged COVID-19 symptom duration among COVID-19 …
disease flare/activity, and prolonged COVID-19 symptom duration among COVID-19 …
Risk of severe COVID-19 outcomes associated with rheumatoid arthritis and phenotypic subgroups: a retrospective, comparative, multicentre cohort study
G Figueroa-Parra, EL Gilbert… - The Lancet …, 2022 - thelancet.com
Background Rheumatoid arthritis has been associated with severe COVID-19, but few
studies have investigated how phenotypes of rheumatoid arthritis affect these associations …
studies have investigated how phenotypes of rheumatoid arthritis affect these associations …
Humoral immunity to an endemic coronavirus is associated with postacute sequelae of COVID-19 in individuals with rheumatic diseases
Beyond the acute illness caused by severe acute respiratory coronavirus 2 (SARS-CoV-2)
infection, about one-fifth of infections result in long-term persistence of symptoms despite the …
infection, about one-fifth of infections result in long-term persistence of symptoms despite the …
Coronavirus disease 2019 outcomes among recipients of anti‐CD20 monoclonal antibodies for immune‐mediated diseases: a comparative cohort study
NJ Patel, KM D'Silva, TYT Hsu, M DiIorio… - ACR open …, 2022 - Wiley Online Library
Objective Patients with immune‐mediated diseases treated with anti‐CD20 monoclonal
antibodies may have worse coronavirus disease 2019 (COVID‐19) outcomes due to …
antibodies may have worse coronavirus disease 2019 (COVID‐19) outcomes due to …
Temporal trends in COVID-19 outcomes among patients with systemic autoimmune rheumatic diseases: from the first wave through the initial Omicron wave
Objectives To investigate temporal trends in incidence and severity of COVID-19 among
patients with systemic autoimmune rheumatic diseases (SARDs) from the first wave through …
patients with systemic autoimmune rheumatic diseases (SARDs) from the first wave through …